HIGH-COST DRUGS ASSESSMENT: TWO-YEAR EXPERIENCE OF A HEALTH TECHNOLOGY ASSESSMENT UNIT IN A REFERRAL CANCER CENTER

被引:0
|
作者
Quirland, C. [1 ]
Lahoz, D. [1 ]
Carreno-Leiton, D. [1 ]
Sanhueza, C. [2 ]
Gonzalez-Browne, C. [1 ]
机构
[1] Arturo Lopez Perez Fdn, Dept Canc Res, Santiago, RM, Chile
[2] Arturo Lopez Perez Fdn, Pharmaceut Serv Dept, Santiago, Chile
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCN167
引用
收藏
页码:S50 / S51
页数:2
相关论文
共 50 条
  • [1] IMPACT OF HEALTH TECHNOLOGY ASSESSMENT IN LITIGATION CONCERNING ACCESS TO HIGH-COST DRUGS
    Aleman, Alicia
    Galan, Ana Perez
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2017, 33 (04) : 411 - 414
  • [2] Two-year experience of a multidisciplinary approach for pediatric thrombosis in a tertiary referral center
    Karakas, Z.
    Tuna, R.
    Aydinli, N.
    Sencer, S.
    Karaman, S.
    Tugcu, D.
    Unuvar, A.
    Durmaz, O.
    Nayir, A.
    Nisli, K.
    Dindar, A.
    Omeroglu, R.
    Darendeliler, F.
    Bayramoglu, Z.
    Ocak, S.
    LEUKEMIA RESEARCH, 2019, 85 : S27 - S27
  • [3] Review of Hematopathology Consult Cases: A Two-Year Experience in a Tertiary Referral Center in Lebanon
    Sinno, Sara A. J.
    Chakhachiro, Zaher I.
    Nassif, Samer R.
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [4] ASSESSMENT OF PATIENT SATISFACTION WITH PUBLIC PHARMACIES DISPENSING HIGH-COST DRUGS IN GREECE
    Georgi, C.
    Georgis, V
    Karakolias, S.
    VALUE IN HEALTH, 2023, 26 (12) : S308 - S309
  • [5] The Challenge of Sustainability of High-Cost Oncological Drugs: A Budgeting Model in an Italian Cancer Center
    Masini, Carla
    Gallegati, Davide
    Gentili, Nicola
    Massa, Ilaria
    Ciucci, Raffaella
    Altini, Mattia
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (24)
  • [6] HOSPITAL BASED HEALTH TECHNOLOGY ASSESSMENT PROGRAM AT KING HUSSEIN CANCER CENTER: ASSESSMENT OF FIVE YEARS EXPERIENCE
    Al Rabayah, A. A.
    Jaddoua, S.
    VALUE IN HEALTH, 2018, 21 : S67 - S67
  • [7] Transforming the organic lab experience: REActivities and assessment of their implementation at a two-year institution
    Anderson, Jason
    Edelbach, Brian
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [8] AUSTRALIAN HEALTH TECHNOLOGY ASSESSMENT OF COMPANION TESTING FOR CANCER DRUGS
    Kim, H.
    Cook, G.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 58 - 58
  • [9] Ultrahypofractionated Proton RT in Prostate Cancer: a single-center two-year experience
    Kataev, N.
    Vorobyov, N.
    Mikhaylov, A.
    Berezina, N.
    Cherkashin, M.
    Kovalik, V.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1223 - S1223
  • [10] Funds Reimbursement of High-Cost Drugs in Gastrointestinal Oncology: An Italian Real Practice 1 Year Experience at the National Cancer Institute of Naples
    Capozzi, Monica
    De Divitiis, Chiara
    Ottaiano, Alessandro
    Teresa, Tramontano
    Capuozzo, Maurizio
    Maiolino, Piera
    Both, Gerardo
    Tafuto, Salvatore
    Avallone, Antonio
    FRONTIERS IN PUBLIC HEALTH, 2018, 6